Clinical Trial Update: Treatment of Human Gingivitis With Amnion-derived Cellular Cytokine Solution (ACCS) [Phase 1]

View source ↗

Summary

This entry notes the completion of a Phase 1 clinical trial evaluating Amnion-derived Cellular Cytokine Solution (ACCS) for gingivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gingivitis

Drugs mentioned

• Amnion-derived Cellular Cytokine Solution (ACCS)

Snippet

Sponsor: Noveome Biotherapeutics, formerly Stemnion | Conditions: Gingivitis | Phase 1 | Status: COMPLETED